Skip to main content

Navigation principale

  • About
  • Team
  • Portfolio
  • Strategy
  • ESG
  • Testimonials
  • News
  • Contact

Secondary Navigation

  • Fr
  • En

Actualités

You are here

  • Home
  • Actualités

BiocSol secures additional €4.4M to develop its sustainable crop protection solutions

Post date
14/02/2025

BiocSol succeeds in its ambition to raise a total of €10M since inception to fast-track the development of its sustainable crop protection solutions - testament to the sector’s growing interest in its

Read more

Eligo Expands Investor Syndicate with Key Strategic Additions

Post date
17/12/2024

Eligo welcomes genetic medicines leader Bobby Gaspar as chair of its board of directors
Oct 1, 2024

  • Dr. Gaspar brings invaluable expertise to gene-editing pioneering company Eligo as it prepares

Read more
Team

Generare raises €5m to scale the discovery of new medicines and molecules hiding in microbes

Post date
17/12/2024

Generare raises €5m to scale the discovery of new medicines and molecules hiding in microbes

  • Generare uses a novel cloning technique to break down microbial DNA and accelerate the discovery of
Read more
Team

BiocSol secures €5.2M seed funding to transform sustainable crop protection

Post date
20/11/2024

BiocSol secures €5.2M seed funding to transform sustainable crop protection with next generation microbial-based solutions, targeting total €10M in funding by year-end
 

  • Built on decade of research
Read more
atb therapeutics

ATB Therapeutics Raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development

Post date
18/11/2024

ATB Therapeutics Raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development
• Financing co-led by EQT Life Sciences and MRL Ventures Fund (MRLV

Read more
VIVES IUF

VIVES IUF Fund raises additional €5M capital from Luxembourg Future Fund 2

Post date
13/09/2024

 

  • New investment from Luxembourg Future Fund 2 brings total funding to €75M, well above original target
  • Deal underlines VIVES’ know-how in connecting academic research and innovative projects with
Read more
Brightflow Raises €16.5M in Series A Financing Round A

Brightflow Raises €16.5M in Series A Financing Round

Post date
10/09/2024

Funding will go towards development of first long-term percutaneous right ventricular assist device

Paris, France, September 10, 2024 – Brightflow SAS, a privately held pioneer in the field of long

Read more
VIVES IUF

VIVES IUF Fund secures €70 million equity to catalyze science into start-up success

Post date
31/01/2024
  • European Investment Fund instrumental in success of second closing 
  • With €38M increased funding capacity, VIVES IUF set to create ten new science-based ventures and support ten current portfolio
Read more
LMO

LMO Space partners with In-Space Missions on AUREA SDA programme

Post date
20/09/2023

LMO (Luxembourg & UK) and In-Space Missions Ltd (UK) have partnered to explore the use of small satellite platforms for space-based Space Domain Awareness (SDA) as part of LMO’s AUREA (Autonomous

Read more
Aphea.Bio

Aphea.Bio secures € 70 million Series C Funding, accelerating the company’s commercialisation efforts

Post date
11/07/2023

New funding will support the rapid growth of Aphea.Bio, solidifying its position as a frontrunner in biological product development for agriculture.

Gent, Belgium, 11 July 2023 – Aphea.Bio, a Belgium

Read more
LMO

LMO has successfully deployed and validated in space a first of a kind autonomous on-orbit identification, characterisation and tracking software on D-Orbit’s platform opening a new era for Space Domain Awareness

Post date
19/05/2023

LMO a dual-use space company focused on space domain awareness, space surveillance and in-orbit servicing has successfully deployed and validated in space a first of a kind autonomous on-orbit

Read more
VOCSens

EnviCam® -30: The New Multi-Gas Microsensor with Unmatched Selectivity, Ultra-Low-Power Consumption and Self-Calibration

Post date
09/05/2023

Mont-Saint-Guibert, 9 th May 2023 – VOCSens unveils EnviCam® -30, its 1 st generation of multi-gas microsensor addressing the request for actionable gas concentration data in Smart Building, Chemical

Read more

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page ››
  • Last page Last »
 

VIVES Funds

VIVES Partners
Chemin du Stocquoy, 1
1300 Wavre
Belgium

Email
info@vivesfund.com
GSM
+32 472 206 355

Contact

Please note that VIVES only invests in companies located in Europe.
Maximum 5 files.
256 MB limit.
Allowed types: txt, rtf, pdf, doc, docx, odt, ppt, pptx, odp, xls, xlsx, ods.
Lire la politique générale de protection des données personnelles.

VIVES is a multi-sector technology fund that invests in spin-offs from UCLouvain and start-ups in Belgium and neighboring countries. The fund has the ability to invest at different stages of a company's development: seed, start-up and growth.

Menu Pied de page

  • Privacy policy & cookies
  • Terms & conditions
  • © 2025 All rights reserved.
  • Website by Visible